Nephros Inc (NEPH): Shareholders' Equity
$10.20M
As of 2025-12-31
$11.97M
As of 2026-06-30
+4.7%
3-year compound annual growth
-8.1%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.20M | +18.8% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $8.59M | +2.7% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $8.36M | -5.9% | 2025-03-24, Balance as of period end |
| 2022-12-31 | $8.88M | -39.8% | 2024-03-15, Balance as of period end |
| 2021-12-31 | $14.75M | -5.3% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $15.57M | +102.5% | 2022-03-03, Balance as of period end |
| 2019-12-31 | $7.69M | +13.1% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $6.80M | +248.6% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $1.95M | n/a | 2019-03-12, Balance as of period end |
| No annual figure between 2012-12-31 and 2017-12-31. | |||
| 2012-12-31 | -$8.72M | n/a | 2015-04-15, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Nephros Inc (NEPH) | 2025-12-31 | $10.20M | +18.8% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $3.10M | -29.8% |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | -$5.73M | n/m |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | -$1.49M | n/m |
| Profound Medical Corp. (PROF) | 2025-12-31 | $66.43M | +10.0% |
| Biotricity Inc. (BTCY) | 2026-03-31 | -$34.68M | n/m |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $67.92M | -5.7% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | $31.22M | -21.5% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | -$77.19M | n/m |
Compare NEPH, SNOA, MDAI, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗